Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur J Pharm Biopharm ; 163: 16-22, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33774161

RESUMEN

In vivo evaluation of arabinoxylans (AX) microspheres showed to protect insulin from degradation in the upper gastrointestinal tract and carrier insulin to colon. Insulin-loaded AX microspheres (50 UI/kg) decreased blood glucose level by 39% in diabetic rats with a maximum effect at 18 h post-administration, indicating that insulin remains bioactive. The continuous administration (4 days) of insulin-loaded AX microspheres improved the polyuria and increased the production of short-chain fatty acids, as well as Bifidobacterium and Bacteroides in diabetic rats compared to untreated diabetic rats. AX microspheres are a potential microbiota-activated carrier for colon-specific drug delivery and could be useful as a complementary treatment for diabetes.


Asunto(s)
Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Portadores de Fármacos/metabolismo , Microbioma Gastrointestinal , Insulina/administración & dosificación , Xilanos/metabolismo , Administración Oral , Animales , Colon/metabolismo , Colon/microbiología , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/microbiología , Diabetes Mellitus Tipo 1/inducido químicamente , Diabetes Mellitus Tipo 1/microbiología , Diabetes Mellitus Tipo 2/inducido químicamente , Diabetes Mellitus Tipo 2/microbiología , Humanos , Insulina/farmacocinética , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiología , Masculino , Microesferas , Ratas , Estreptozocina/administración & dosificación , Estreptozocina/toxicidad
2.
Int J Biol Macromol ; 126: 952-959, 2019 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-30584929

RESUMEN

Arabinoxylans (AX) microspheres with different insulin/AX mass ratio were prepared by formation of phenoxy radical issued from the ferulic acid by enzymatic oxidation (entrapped in situ of insulin). Phenolic acid content and FT-IR spectrum of unloaded and insulin-loaded AX microspheres revealed that the phenoxy radical issued from the ferulic acid by enzymatic oxidation did not interact covalently with insulin. The microspheres showed a spherical shape, smooth surface and an average diameter of particles of 320 µm. In vitro control release found that AX microspheres minimized the insulin loss in the upper GI tract, retaining high percentage (~75%) of insulin in its matrix. The stability of the secondary structure of insulin was studied by dichroism circular (CD). The CD spectra of insulin released from AX microspheres did not change according to the insulin/AX mass ratio of the microsphere. Significant hypoglycemic effects with improved insulin-relative bioavailability tested on an in vivo murine model revealed the efficacy of these enzymatically cross-linked arabinoxylans microspheres as a new oral insulin carrier.


Asunto(s)
Reactivos de Enlaces Cruzados/química , Sistemas de Liberación de Medicamentos , Insulina/administración & dosificación , Lacasa/metabolismo , Microesferas , Xilanos/química , Administración Oral , Animales , Glucemia/metabolismo , Liberación de Fármacos , Humanos , Masculino , Ratas Wistar , Reología , Espectroscopía Infrarroja por Transformada de Fourier , Distribución Tisular
3.
J Agric Food Chem ; 49(2): 946-51, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11262054

RESUMEN

Flame Seedless grapes were sprayed with N-(2-chloro-4-pyridyl)-N-phenylurea (CPPU) at 0, 2.5, and 5.0 ppm to develop rachis resistant to browning and dehydration. Rachis polyphenol oxidase (PPO) activity was determined during cluster development. Cluster components were weighed at commercial (CM), and physiological maturity (PM). PPO activity, rachis color changes (L and a), and cluster weight loss were evaluated at 0 degrees C for 8, 16, 32, and 56 days. CPPU-treated rachis had a decrease of 36% in PPO activity and a week delay in peak activity. At PM, dry weight of CPPU-treated rachis increased by 3 g. Postharvest rachis PPO activity declined with CPPU application, and color changes followed the same pattern for CM and PM. After 32 days of storage, L and a in lateral branches were significantly superior in CPPU treatments. Weight losses below 2.1% were significantly lowest in CPPU-treated clusters for 16 days of storage regardless of cluster maturity.


Asunto(s)
Catecol Oxidasa/metabolismo , Compuestos de Fenilurea/farmacología , Tallos de la Planta/enzimología , Piridinas/farmacología , Rosales/enzimología , Catecol Oxidasa/efectos de los fármacos , Color , Citocininas/farmacología , Desecación , Manipulación de Alimentos , Reacción de Maillard/efectos de los fármacos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA